Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0UL2L
|
||||
Former ID |
DIB015995
|
||||
Drug Name |
Lornoxicam
|
||||
Synonyms |
CTX; Chlortenoxicam; Lorcam; Safem; Telos; Xefo; Xefo Rapid; HN-10000; TS-110; Ro-13-9297
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Roche Holding AG
|
||||
Structure |
Download2D MOL |
||||
Formula |
C13H10ClN3O4S2
|
||||
Canonical SMILES |
S1(=O)(=O)c2c(C(=C(N1C)C(=O)Nc1ncccc1)O)sc(c2)Cl
|
||||
CAS Number |
CAS 70374-39-9
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cyclooxygenase | Target Info | Modulator | [525560], [551871] | |
References | |||||
Ref 525560 | The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro. Inflamm Res. 1999 Jul;48(7):369-79. | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.